Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Martinez

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Kidney International Reports|August 15, 2025
Lipidomics Unveils Critical Lipid Pathway Shifts in Alport SyndromeBelen Requena, Amir Shabaka, Borja Lanzon, et al.
The Science of the Total Environment|March 5, 2022
Structural shifts in sea ice prokaryotic communities across a salinity gradient in the subarcticLígia Fonseca Coelho, Joana Fernandes Couceiro, Tina Keller-Costa, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activityNicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Acta Neuropathologica Communications|October 16, 2019
Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatmentsHélène Party, Cléo Dujarrier, Marie Hébert, et al.
Developmental Neurobiology|July 21, 2018
Cerebrospinal fluid flow increases from newborn to adult stagesCamille Di Palma, Romain Goulay, Sebastien Chagnot, et al.
European Journal of Immunology|January 18, 2008
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosisIvan Martinez-Forero, Ricardo Garcia-Munoz, Sara Martinez-Pasamar, et al.
Science Advances|July 20, 2022
Tracking the immune response by MRI using biodegradable and ultrasensitive microprobesSara Martinez de Lizarrondo, Charlene Jacqmarcq, Mikael Naveau, et al.
Investigational New Drugs|September 17, 2025
Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumorsAlejandro Falcón, Santiago Ponce, Gregory M Cote, et al.
Investigational New Drugs|August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumorsMohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Ultra-Fast Multi-Organ Proteomics Unveils Tissue-Specific Mechanisms of Drug Efficacy and ToxicityYun Xiong, Lin Tan, Wai-Kin Chan, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Kidney International Reports|August 15, 2025
Lipidomics Unveils Critical Lipid Pathway Shifts in Alport SyndromeBelen Requena, Amir Shabaka, Borja Lanzon, et al.
The Science of the Total Environment|March 5, 2022
Structural shifts in sea ice prokaryotic communities across a salinity gradient in the subarcticLígia Fonseca Coelho, Joana Fernandes Couceiro, Tina Keller-Costa, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activityNicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Acta Neuropathologica Communications|October 16, 2019
Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatmentsHélène Party, Cléo Dujarrier, Marie Hébert, et al.
Developmental Neurobiology|July 21, 2018
Cerebrospinal fluid flow increases from newborn to adult stagesCamille Di Palma, Romain Goulay, Sebastien Chagnot, et al.
European Journal of Immunology|January 18, 2008
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosisIvan Martinez-Forero, Ricardo Garcia-Munoz, Sara Martinez-Pasamar, et al.
Science Advances|July 20, 2022
Tracking the immune response by MRI using biodegradable and ultrasensitive microprobesSara Martinez de Lizarrondo, Charlene Jacqmarcq, Mikael Naveau, et al.
Investigational New Drugs|September 17, 2025
Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumorsAlejandro Falcón, Santiago Ponce, Gregory M Cote, et al.
Investigational New Drugs|August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumorsMohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Ultra-Fast Multi-Organ Proteomics Unveils Tissue-Specific Mechanisms of Drug Efficacy and ToxicityYun Xiong, Lin Tan, Wai-Kin Chan, et al.
Pageof 10